About us
ICON Development Solutions' Clinical Research Unit in Manchester was formed in 1983, originally under the name of Medeval which evolved from the University of Manchester's Pharmacy Department. Today we are part of ICON plc, a global company with 48 offices in 30 countries - for more information visit www.iconclinical.com
Currently the Clinical Research Unit has an 80-bed capacity, making us one of the largest dedicated Phase 1 clinical research organisations in Europe.
We have been conducting clinical studies for over 25 years and our reputation for safety, scientific integrity and compliance allows us to enjoy a first class reputation with clients from major pharmaceutical companies and volunteers who participate in our studies.
The safety of all volunteers is our primary concern at ICON Development Solutions. All our studies are conducted under internationally agreed guidelines set down by the US Food and Drug Administration (FDA) and the UK Medicine and Healthcare Products Regulatory Agency (MHRA). Each study is reviewed by an Independent Ethics Committee who are responsible for ensuring that your safety has been thoroughly considered, that the information provided to you is fair, balanced and accurate and that your rights as a volunteer are maintained.
We really do value our volunteers who we rely on to help with our studies. In return for your time and commitment you will be compensated upto £3500! Although our volunteers are compensated financially many take part because they’re keen to help the world of medicine progress new treatments which may improve the quality of life of people all over the World. Sign up today...do Something To Be Proud Of